Cardio fitness DNA testing specialist, Rightangled has joined the Association of British HealthTech Industries' (ABHI) Innovation Hub, a unique partnership between the ABHI and the Dell Medical School at The University of Texas at Austin.
Rightangled and its stakeholders from the NHS are further expanding UK’s Med Tech outreach to the US. Rightangled has recently been engaging and signing up service agreements with logistic suppliers, accredited labs and other partners in the US with whom it will be delivering its services to the American consumer.
“When we released our initial product, the Heart DNA test, our first online order came from the US. For us that was a sign, and now the US is 20% of our monthly sales," said Abdullah Sabyah, co-founder and CEO of Rightangled. This organic US growth has been taking place without a marketing campaign or local business development.”
The ABHI Innovation Hub located within Dell Med’s Health CoLab offers the opportunity for Rightangled to be located within a world-class facility and to continue the development of future US business within an ecosystem of clinicians, investors and mentors. It also provides an infrastructure to strengthen market access and clinician engagement in Texas and beyond.
Philip Kennedy, chair of the ABHI, said: “The ABHI Innovation Hub at Dell Medical School will offer Rightangled a unique opportunity to collaborate in a truly world class facility. The Hub will support promising health technology innovation whilst looking to develop value-based healthcare for the benefit of patients in Texas, throughout the US and at home in the UK."
The Dell Medical School has a strong focus on supporting health entrepreneurs and businesses. Being part of the Innovation Hub also means Rightangled will also be able to participate in the 'Texas Health Catalyst,' a programme designed by the Dell Medical School to foster health research and advance innovation.
